Members |
targetComponentId |
Urine microscopy: cells NOS |
Urine microscopy for cells (procedure) |
Urine microscopy: crystals NOS |
Urine microscopy: crystals - finding |
Urine microscopy: crystals NOS |
Urine microscopy for crystals |
Urine microscopy: leucs - % lymphs |
Urine microscopy for percentage of lymphocytes (procedure) |
Urine microscopy: leucs - % polys |
Urine microscopy for percentage of polymorphonuclear leukocytes |
Urine microscopy: no cells |
No cells seen in urine via microscopy |
Urine microscopy: no cells |
No cells seen in urine via microscopy |
Urine microscopy: no epithelial cells |
No epithelial cells seen in urine via microscopy (finding) |
Urine microscopy: no white cells |
No leukocytes seen in urine via microscopy |
Urine microscopy: orgs/FB's NOS (procedure) |
Urine microscopy for organisms AND/OR foreign bodies |
Urine pH NOS |
Urine pH test |
Urine pH NOS |
Urine pH test |
Urine pregnancy test NOS |
Urine pregnancy test (procedure) |
Urine pregnancy test NOS |
Urine pregnancy test (procedure) |
Urine protein (& level) |
Measurement of protein in urine (procedure) |
Urine protein |
Protein |
Urine protein NOS |
Measurement of protein in urine (procedure) |
Urine protein NOS |
Measurement of protein in urine (procedure) |
Urine protein electrop. NOS |
Urine protein electrophoresis |
Urine protein electrop. NOS |
Urine protein electrophoresis |
Urine protein test NOS |
Measurement of protein in urine (procedure) |
Urine protein test NOS |
Measurement of protein in urine (procedure) |
Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
Urine screening NOS |
Urine screening status |
Urine screening NOS |
Urine screening |
Urine sex hormone 24 hour assay NOS |
Urine sex hormone 24 hour assay |
Urine sex hormone 24 hour assay NOS |
Urine sex hormone 24 hour assay |
Urine sex hormone titer NOS |
Urine sex hormone measurement |
Urine sex hormone titre NOS |
Urine sex hormone measurement |
Urine specific gravity NOS |
Urinalysis, specific gravity measurement |
Urine specific gravity NOS |
Urinalysis, specific gravity measurement |
Urine test NOS |
Urine examination |
Urine test NOS |
Urine examination |
Urine urobilinogen test NOS |
Urobilinogen measurement, urine |
Urine urobilinogen test NOS |
Urobilinogen measurement, urine |
Urine volume |
Urine volume measurement finding (finding) |
Urine volume over other time |
Urine sample volume measurement |
Urine volume over other time (& level) |
Urine sample volume measurement |
Urine volume over other time |
Urine sample volume measurement |
Urobilinogenemia |
Urobilinogen level above reference range (finding) |
Urofollitrophin 150units powder and solvent for injection solution ampule |
Product containing only urofollitropin (medicinal product) |
Urofollitrophin 150units powder for conventional release solution for injection ampule |
Product containing only urofollitropin (medicinal product) |
Urofollitropin 75iu powder and solvent for injection solution ampule |
Product containing only urofollitropin (medicinal product) |
Urofollitropin 75iu powder for conventional release solution for injection ampule |
Product containing only urofollitropin (medicinal product) |
Urofollitropin 75iu powder for injection solution ampule |
Urofollitropin 150 unit/mL solution for injection |
Urokinase 250000iu powder for injection solution vial |
Product containing only urokinase (medicinal product) |
Urokinase 50000units/mL injection solution vial |
Urokinase 50000 unit/mL solution for injection |
Uroporphyrinogen synthase |
Hydroxymethylbilane synthase |
Uroporphyrinogen-1 synthase |
Hydroxymethylbilane synthase |
Urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
Urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
Urticaria pigmentosa |
Cutaneous mastocytosis (morphologic abnormality) |
Urticaria pigmentosa, diffuse erythrodermic type |
Diffuse erythrodermic mastocytosis (disorder) |
Urticaria pigmentosa, maculopapular type |
Cutaneous mastocytosis (disorder) |
Urticaria pigmentosa, multiple nodules AND/OR plaques |
Cutaneous mastocytosis (disorder) |
Urticaria pigmentosa, solitary cutaneous nodule |
Solitary cutaneous mastocytoma (disorder) |
Urticaria pigmentosa, telangiectasia macularis eruptiva perstans |
Telangiectasia macularis eruptiva perstans |
Uses prostitutes |
Client of prostitutes |
Using interatrial baffle |
Repair - action |
Ustekinumab 90mg/mL injection solution |
Product containing only ustekinumab (medicinal product) |
Uterine cervix TNM finding |
American Joint Committee on Cancer allowable value |
Uterine fibroid affecting obstetric care |
Uterine fibroids in pregnancy, childbirth and the puerperium |
Uterine foreign body - vaginal removal NOS |
Vaginal removal of uterine foreign body |
Uterine foreign body - vaginal removal NOS |
Vaginal removal of uterine foreign body |
Uterine incoordination |
Dyscoordinate labor |
Uterine scar from previous surgery in pregnancy, childbirth and the puerperium with antenatal problem |
Uterine scar from previous surgery affecting pregnancy |
Uveal melanoma TNM finding |
American Joint Committee on Cancer allowable value |
V - volt |
volt (qualifier value) |
V-Y operation for ectropion |
Repair of ectropion of skin of eyelid using local V-Y advancement flap (procedure) |
V-Y operation of lip |
Reconstruction of skin of lip using local V-Y advancement flap |
V-Y operation of skin and subcutaneous tissue without skin graft |
Reconstruction of skin using local V-Y advancement flap (procedure) |
Vabra curette |
Curette |
Vaccination required |
Requires vaccination (finding) |
Vaccination required |
Requires vaccination (finding) |
Vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) |
COVID-19 vaccine |
Vaccine product containing only Human papillomavirus 9 antigen (medicinal product) |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) |
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) |
Inactivated whole Human poliovirus antigen only vaccine product |
Vacuum delivery NOS |
Delivery by vacuum extraction |
Vagal bradycardia |
Vagal autonomic bradycardia |
Vagina TNM finding |
American Joint Committee on Cancer allowable value |
Vaginal abnormality affecting obstetric care |
Vaginal abnormality in pregnancy, childbirth and the puerperium |
Vaginal discharge NOS |
Vaginal discharge |
Vaginal discharge NOS |
Vaginal discharge |
Vaginal disorder NOS |
Disorder of vagina |
Vaginal disorder NOS |
Disorder of vagina |
Vaginal hysterocolpectomy NEC |
Vaginal hysterocolpectomy |
Vaginal hysterocolpectomy NEC |
Vaginal hysterocolpectomy |
Vaginal incision NOS |
Incision of vagina |
Vaginal incision NOS |
Incision of vagina |
Vaginal operation to support outlet of female bladder NOS |
Surgical procedure on outlet of urinary bladder (procedure) |
Vaginal operations to support outlet of female bladder |
Surgical procedure on outlet of urinary bladder (procedure) |
Vaginal outlet |
Vaginal introitus structure |
Vaginal repair: [NOS] or [Fothergill] |
Manchester-Fothergill operation on uterus |
Vaginal ulcertion |
Vaginal ulcer |
Vaginal vault smear NOS |
Sampling of vaginal vault for smear (procedure) |
Vaginal vault smear NOS |
Sampling of vaginal vault for smear (procedure) |
Valacyclovir hydrochloride 1g caplet |
Valaciclovir (as valaciclovir hydrochloride) 1 g oral tablet |
Valganciclovir 50mg/mL powder for oral solution |
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
Valproate sodium 100mg/mL solution for injection |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |